Process for making topotecan
    4.
    发明申请
    Process for making topotecan 有权
    拓扑替康的制备方法

    公开(公告)号:US20090221826A1

    公开(公告)日:2009-09-03

    申请号:US12082162

    申请日:2008-04-09

    IPC分类号: C07D491/147

    CPC分类号: C07D491/22 Y02P20/55

    摘要: A process of making topotecan or a pharmaceutically acceptable salt thereof comprising reacting an iminium salt with 10-hydroxy-camptothecin.

    摘要翻译: 制备拓扑替康或其药学上可接受的盐的方法,其包括使亚铵盐与10-羟基喜树碱反应。

    Novel crystal forms of irinotecan hydrochloride
    6.
    发明申请
    Novel crystal forms of irinotecan hydrochloride 有权
    盐酸伊立替康的新型晶体形式

    公开(公告)号:US20070072890A1

    公开(公告)日:2007-03-29

    申请号:US11523367

    申请日:2006-09-19

    IPC分类号: A61K31/4745 C07D491/22

    CPC分类号: C07D491/22

    摘要: The present invention provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating metastatic carcinoma of the colon or rectum using same.

    摘要翻译: 本发明提供了伊立替康盐酸盐的新结晶形式及其制备方法,其含有使用其可治疗结肠或直肠转移性癌的新形式和方法的药物组合物。

    Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin
    7.
    发明授权
    Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin 有权
    7-乙基-10-羟基喜树碱的结晶多晶型物

    公开(公告)号:US08138343B2

    公开(公告)日:2012-03-20

    申请号:US12215006

    申请日:2008-06-24

    IPC分类号: C07D491/22

    CPC分类号: C07D491/147

    摘要: A crystalline polymorph of 7-ethyl-10-hydroxycamptothecin exhibiting an X-ray diffraction pattern having peaks at 10.9±0.2, 13.2±0.2, 23.9±0.2, and 26.1±0.2 2-theta degree.

    摘要翻译: 表现出具有在10.9±0.2,13.2±0.2,23.9±0.2和26.1±0.22θ度的峰的X射线衍射图的7-乙基-10-羟基喜树碱的结晶多晶型物。

    Crystal forms of irinotecan hydrochloride
    8.
    发明授权
    Crystal forms of irinotecan hydrochloride 有权
    盐酸伊立替康的晶体形式

    公开(公告)号:US07435818B2

    公开(公告)日:2008-10-14

    申请号:US11523367

    申请日:2006-09-19

    IPC分类号: C07D491/22

    CPC分类号: C07D491/22

    摘要: The present invention provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating metastatic carcinoma of the colon or rectum using same.

    摘要翻译: 本发明提供了伊立替康盐酸盐的新结晶形式及其制备方法,其含有使用其可治疗结肠或直肠转移性癌的新形式和方法的药物组合物。